MICHELLE FLINT: Open Payments
NPI 1841908969 · MIAMI BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,894 in 98 payments from 35 companies in 2025. Trend: 2023 $2,516 · 2024 $3,305 · 2025 $4,894
Consulting: $2,700Food & beverage: $2,194
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $2,380 |
| ABBVIE INC. | 5 | $735 |
| Janssen Biotech, Inc. | 10 | $216 |
| Merck Sharp & Dohme LLC | 9 | $185 |
| Daiichi Sankyo Inc. | 6 | $140 |
| Incyte Corporation | 5 | $116 |
| Novartis Pharmaceuticals Corporation | 7 | $112 |
| Aveo Pharmaceuticals, Inc. | 3 | $87 |
| SERVIER PHARMACEUTICALS LLC | 3 | $83 |
| Eisai Inc. | 4 | $83 |
Products named: LYNPARZA, ELAHERE, Enhertu, KEYTRUDA, DARZALEX, CARVYKTI, FOTIVDA, Lenvima.
Industry payments across FL — which companies pay providers there.
